Company intelligence / Profile preview

Mycocycle

Bolingbrook, Illinois, United Statesmycocycle.com ↗

Ownership: Private
Development stage: Commercial

Overview

Mycocycle has developed a patent-pending process that uses fungi—specifically mycelium—to break down industrial and construction waste into non-toxic raw materials. Their technology enables the creation of low-carbon building products such as insulation and foam alternatives. The company has demonstrated significant scale-up in production capacity and established partnerships with major industry players to divert large volumes of waste from landfills.

Modalities: Microbial therapy (specifically fungal/mycelium-based bioprocessing)
Industry: Non-Drug Biotech

Partnerships

TarkettGenslerDPR Construction

Beyond the preview

Go deeper on Mycocycle.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mycocycle.

Explore the full profile